Bosh sahifaDEMG • LON
add
Deltex Medical Group plc
Yopilish kursi
0,080 GBX
Yillik diapazon
0,072 GBX - 0,20 GBX
Bozor kapitalizatsiyasi
1,52 mln GBP
Oʻrtacha hajm
1,35 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
LON
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(GBP) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 532,00 ming | 0,47% |
Joriy xarajat | 576,50 ming | 0,70% |
Sof foyda | -273,00 ming | -1,68% |
Sof foyda marjasi | -51,32 | -1,20% |
Har bir ulushga tushum | — | — |
EBITDA | -201,50 ming | -6,33% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
(GBP) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 326,00 ming | 204,67% |
Jami aktivlari | 5,50 mln | -7,47% |
Jami passivlari | 2,81 mln | -31,48% |
Umumiy kapital | 2,69 mln | — |
Tarqatilgan aksiyalar | 1,89 mlrd | — |
Narxi/balansdagi bahosi | ∞ | — |
Aktivlardan daromad | -10,05% | — |
Kapitaldan daromad | -11,83% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(GBP) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | -273,00 ming | -1,68% |
Operatsiyalardan naqd pul | -217,50 ming | -42,62% |
Sarmoyadan naqd pul | 1,00 ming | 100,83% |
Moliyadan naqd pul | 21,50 ming | -77,37% |
Naqd pulning sof oʻzgarishi | -189,50 ming | -4,12% |
Boʻsh pul | -113,12 ming | 53,54% |
Haqida
Deltex Medical Group is a medical technology company based in Chichester that produces blood monitoring and fluid management equipment for use in surgical operations.
It has sold 3000 of its main product, the ultrasound probe CardioQ-ODM, which measures the rate of blood flow from the heart. The company claims that it has been shown to reduce postoperative complications and reduce length of hospital stay. According to the National Institute for Health and Care Excellence it could save £1000 per operation and could be used on more than 800,000 patients a year. As it is inserted into the gullet, it reduces the risk of infection that comes with monitoring using a tube inserted through a vein into the heart. Each probe costs about £100.
It secured approval from the NHS Supply Chain in 2012 after a tender process, to sell cardiac output monitoring equipment to the NHS in England, meaning that individual NHS trusts did not have to go through a tender process. In November 2016 an NHS hospital bought six, the largest order since 2014. The cash crisis affecting the NHS has meant that few machines have been bought. Wikipedia
Tashkil etilgan
2000
Xodimlar soni
24